Total Payments
$1,064
2024 Payments
$192.08
Companies
7
Transactions
19
Medicare Patients
357
Medicare Billing
$52,778
Payment Breakdown by Category
Food & Beverage$1,031 (96.9%)
Education$32.70 (3.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,031 | 14 | 96.9% |
| Education | $32.70 | 5 | 3.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $277.74 | 4 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $240.79 | 3 | $0 (2021) |
| Amarin Pharma Inc. | $161.21 | 5 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $140.00 | 3 | $0 (2019) |
| Amgen Inc. | $99.68 | 2 | $0 (2018) |
| Corcept Therapeutics | $75.26 | 1 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $68.90 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $192.08 | 3 | Novo Nordisk Inc ($116.82) |
| 2021 | $164.69 | 3 | Boehringer Ingelheim Pharmaceuticals, Inc. ($95.79) |
| 2019 | $488.79 | 10 | Amarin Pharma Inc. ($161.21) |
| 2018 | $218.02 | 3 | Novo Nordisk Inc ($118.34) |
All Payment Transactions
19 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/18/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $60.67 | General |
| 10/17/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $75.26 | General |
| Category: Endocrinology | ||||||
| 10/17/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $56.15 | General |
| 10/16/2021 | Merck Sharp & Dohme Corporation | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $68.90 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/15/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $48.36 | General |
| Category: DIABETES | ||||||
| 10/15/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $47.43 | General |
| 11/15/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Education | In-kind items and services | $9.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/11/2019 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 10/10/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $145.00 | General |
| Category: DIABETES | ||||||
| 10/10/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $74.99 | General |
| Category: Hypertriglyceridemia | ||||||
| 10/10/2019 | Novo Nordisk Inc | Victoza (Drug) | Food and Beverage | In-kind items and services | $42.58 | General |
| Category: Diabetes | ||||||
| 05/28/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Education | In-kind items and services | $5.90 | General |
| Category: Hypertriglyceridemia | ||||||
| 05/07/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Education | In-kind items and services | $5.90 | General |
| Category: Hypertriglyceridemia | ||||||
| 05/03/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $68.52 | General |
| Category: Hypertriglyceridemia | ||||||
| 04/10/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Education | In-kind items and services | $5.90 | General |
| Category: Hypertriglyceridemia | ||||||
| 02/11/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Education | In-kind items and services | $6.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/26/2018 | Novo Nordisk Inc | Victoza (Drug) | Food and Beverage | In-kind items and services | $118.34 | General |
| Category: Diabetes | ||||||
| 10/24/2018 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: Cardiology | ||||||
| 05/04/2018 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $49.68 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 52 | 117 | $13,925 | $9,066 |
| 2022 | 2 | 50 | 113 | $13,420 | $9,068 |
| 2021 | 8 | 152 | 287 | $22,973 | $17,264 |
| 2020 | 3 | 103 | 243 | $24,360 | $17,380 |
Total Patients
357
Total Services
760
Medicare Billing
$52,778
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 27 | 55 | $7,705 | $4,909 | 63.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 25 | 62 | $6,220 | $4,157 | 66.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 25 | 53 | $7,420 | $5,118 | 69.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 25 | 60 | $6,000 | $3,950 | 65.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 36 | 108 | $10,305 | $7,517 | 72.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 32 | 60 | $8,172 | $6,092 | 74.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 13 | 13 | $1,808 | $1,783 | 98.6% |
| 99446 | Telephone or internet assessment and management service provided by consultative physician with verbal and written report, 5-10 minutes of medical consultative discussion and review | Office | 2021 | 19 | 42 | $895.00 | $646.80 | 72.3% |
| 99447 | Telephone or internet assessment and management service provided by consultative physician with verbal and written report, 11-20 minutes of medical consultative discussion and review | Office | 2021 | 11 | 14 | $598.00 | $333.06 | 55.7% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 11 | 20 | $400.00 | $320.00 | 80.0% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent, preservation free | Office | 2021 | 15 | 15 | $345.00 | $307.95 | 89.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 15 | 15 | $450.00 | $263.55 | 58.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 44 | 146 | $12,300 | $8,381 | 68.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 36 | 74 | $8,920 | $6,248 | 70.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 23 | 23 | $3,140 | $2,751 | 87.6% |
About Dr. Bassam Hamid, MD
Dr. Bassam Hamid, MD is a Internal Medicine healthcare provider based in Baytown, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1902913064.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bassam Hamid, MD has received a total of $1,064 in payments from pharmaceutical and medical device companies, with $192.08 received in 2024. These payments were reported across 19 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($1,031).
As a Medicare-enrolled provider, Hamid has provided services to 357 Medicare beneficiaries, totaling 760 services with total Medicare billing of $52,778. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Baytown, TX
- Active Since 08/24/2006
- Last Updated 05/30/2008
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1902913064
Products in Payments
- JARDIANCE (Drug) $193.36
- Vascepa (Drug) $161.21
- Victoza (Drug) $160.92
- Repatha (Biological) $99.68
- Korlym (Drug) $75.26
- VERQUVO (Drug) $68.90
- FARXIGA (Drug) $15.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Baytown
Dr. Dinara Rose, M.d, M.D
Internal Medicine — Payments: $7,729
Internal Medicine $7,729
Dr. Luis Gonzalez, M.d, M.D
Internal Medicine — Payments: $6,904
Internal Medicine $6,904
Atif Qureshi, M.d, M.D
Internal Medicine — Payments: $6,870
Internal Medicine $6,870
Shehzad Sami, Md, MD
Internal Medicine — Payments: $5,864
Internal Medicine $5,864
Kamran Khan, Md, MD
Internal Medicine — Payments: $4,512
Internal Medicine $4,512
Dr. Niravkumar Naik, M.d, M.D
Internal Medicine — Payments: $4,481
Internal Medicine $4,481